跳至主要内容
临床试验/IRCT20220607055097N2
IRCT20220607055097N2已完成4 期

Comparison of the Efficacy of Diclofenac 0.1% and Nepafenac 0.1% on anterior chamber cells in patients Undergoing Cataract Surgery: a Prospective clinical practice trial

owshera Medical College/ Qazi Hussain Ahmad Medical Complex0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
All

入选标准

  • Patients’ = 50 yrs.
  • Both males and females
  • with visually significant senile-cataracts under-going phacoemulsification with intra-ocular lens implantation

排除标准

  • Any past intra-ocular surgery
  • Any history of any intra-ocular inflammatory diseases,
  • Traumatic globe injuries
  • Corneal disorders impairing the view
  • Any glaucomatous diseases of eye
  • Pseudo-exfoliation cataracts
  • any retinal/macular abnormalities, such as macular edema due to other etiologies or epi-retinal membranes or any age-related maculopathy.
  • Those not willing to follow the study protocols and requirements of follow up
  • Those who were pre-diabetics and confirmed diabetics
  • Those with systemic autoimmune/inflammatory disorders or any history of allergic reaction to the study drugs or other NSAIDs
  • Patients with eventful phaco surgery such as posterior-capsular tear, vitreous-prolapse or post-operative fibrinous reactions

研究者

发起方
owshera Medical College/ Qazi Hussain Ahmad Medical Complex

相似试验

Effect of Diclofenac 0.1% Vs. Nepafenac 0.1% on... | 临床试验